[1. Panamerican Health Organization. Poors desease [Internet]. 2009 [cited 2009 Mar 4]. Available from: http://www.paho.org/Spanish/AD/DPC/CD/psit-ndposter.htm]Search in Google Scholar
[2. Brenner D, Kaufmann A, Sulzer K, Steigerwalt A, Rogers F, Weyant R. Further determination of DNA relatedness between serogroups and serovars in the family Leptospiraceae with a proposal for Leptospira alexanderi sp. and four new Leptospira genomospecies. Int J Syst Bacteriol. 1999; 49:839-58.10.1099/00207713-49-2-839]Open DOISearch in Google Scholar
[3. Adler B, de la Peña M. Leptospira and Leptospirosis. Vet Microbiol. 2009; 2:4382-92.]Search in Google Scholar
[4. Levett P. Leptospirosis. Clin Microbiol Rev. 2001; 14: 296-326.10.1128/CMR.14.2.296-326.2001]Open DOISearch in Google Scholar
[5. Cinco M, Domenis R, Perticarari S, Presani G, Marangoni A, Blasi E. Interaction of leptospires with murine microglial cells. New Microbiol. 2006; 29:193-9.]Search in Google Scholar
[6. McBride A, Athanazio D, Reis M, Ko A. Leptospirosis. Curr Opin Infect Dis. 2005; 18:376-86.10.1097/01.qco.0000178824.05715.2c]Open DOISearch in Google Scholar
[7. WHO/FAO/OIE Collaborating Centre for Reference and Research on Leptospirosis. National Leptospirosis Surveillance Report number 17 [Internet]. 2009 [cited 2009 Mar 4]. Available from: http://www.health.qld.gov.au/qhcss/documents/lepto/08_annual.pdf;2009]Search in Google Scholar
[8. World Health Organization. WHO Guidelines on Non-clinical Evaluation of Vaccines. 2003.]Search in Google Scholar
[9. Faine S. Leptospira and Leptospirosis. Clayton, Victoria, Australia: CRC Press. 1994.]Search in Google Scholar
[10. Haake D, Chao G, Zuerner R, Barnett J, Barnett D, Mazel M. The leptospiral major outer membrane protein LipL32 is a lipoprotein expressed during mammalian infection. Infect Immun. 2000; 68:2276-85.10.1128/IAI.68.4.2276-2285.2000]Open DOISearch in Google Scholar
[11. Andre-Fontaine G, Branger C, Gray A, Klaasen H. Comparison of the efûcacy of three commercial bacterins in preventing canine leptospirosis. Vet Rec. 2003; 153:165-9.10.1136/vr.153.6.165]Open DOISearch in Google Scholar
[12. Wan Z, Jin L, Wegrzyn A. Leptospirosis vaccines. Microb Cell Fac. 2007; 6:1-10.10.1186/1475-2859-6-1]Open DOISearch in Google Scholar
[13. Martínez R, Pérez A, Baró M, Alvarez M, Menéndez J, Díaz M. Evaluation of the effectiveness of a new vaccine against human leptospirosis in groups at risk. Rev Panam Sal Pub. 2000; 8:385-92.]Search in Google Scholar
[14. Rodríguez I, Fernández C, Obregon A, Zamora Y, Rodríguez J, Rodríguez N. Epidemological behavior of the leptospirosis in Cuba 2006-2008, Leptospirosis Havana 2009. Proceedings of I SAW Scientific Meeting, 2009 Jun 8-12; Havana, Cuba.]Search in Google Scholar
[15. Haake D. Hamster model of leptospirosis. Curr Protoc Microb. 2006 Sep;Chapter 12:Unit 12E.2.10.1002/9780471729259.mc12e02s02]Open DOISearch in Google Scholar
[16. Silva E, Santos S, Athanazio D, Seyffert N, Seixas F, Cerqueira G. Characterization of virulence of Leptospira isolates in a hamster model. Vaccine. 2008; 26:3892-6.10.1016/j.vaccine.2008.04.085]Open DOISearch in Google Scholar
[17. González M, Martínez R, Cruz R, Infante J, González I. vax-SPIRALR. Trivalent antileptospirosic vaccine for human use, investigation, development and impact on the illness in Cuba. Biotec. Aplic. 2004; 2:107-11.]Search in Google Scholar
[18. American Veterinary Medical Association. Guidelines on Euthanasia. Fromerly report of the AVMA panel on Euthanasia; 2007.]Search in Google Scholar
[19. Silva E, Medieros M, Mc Bride A, Matasunga J, Esteves G, Ramos J. The terminal portion of leptospiral immunoglobulin-like protein Lig A confers protective immunity against lethal infection in the hamster model of leptospirosis. Vaccine. 2007; 25:6277-86.10.1016/j.vaccine.2007.05.053]Open DOISearch in Google Scholar
[20. Reed J, Muench H. simple method of estimation ûfty percent end-points. American Journal of Hygiene. 1938; 27:493-7.]Search in Google Scholar
[21. Finlay Institute. Sanitary Registration of vax- SPIRAL (trivalent antileptospirosic vaccine); 1998. p.23-25.]Search in Google Scholar
[22. Freudenstein H, Hein B. Potency of Leptospiral vaccines and protection against chronic infection in golden hamsters. Comp Immunol Microb Infect Dis. 1991; 14:229-34.10.1016/0147-9571(91)90003-V]Open DOISearch in Google Scholar
[23. Tepstra W, Hartskeerl R, Smits H, Korver H. International Course in Laboratory Techniques for the Diagnosis of Leptospirosis. KIT Biomedical Research. International. Royal Tropical Institute, Amsterdam, 2006, 1-124.]Search in Google Scholar
[24. Hem A, Smith A, Solberg P. Saphenous vein puncture for blood sampling of the mouse, rat, hamster, gerbil, guinea pig, ferret, and mink. Lab Anim. 1998; 32:364-8.10.1258/002367798780599866]Open DOISearch in Google Scholar
[25. Silva M, Camargo E, Batista L, Vaz A, Brandao A, Nakamura P. Behaviour of specific IgM, IgG and IgA class antibodies in human leptospirosis during the acute phase of the disease and during convalescence. J Trop Med Hyg. 1995; 98:268-72.]Search in Google Scholar
[26. Nu ez J, Fajardo E, Perez E, Ontivero I, Silva D, Munoz P. Evaluation of two different potency tests for leptospirosis vaccine vax-spiral. Rev Cub Med Tropic. 2005; 57:67-8.]Search in Google Scholar
[27. Falkow S. Molecular Koch’s postulates applied to microbial pathogenicity. Rev Infect Dis. 1988; 10: 274-6.10.1093/cid/10.Supplement_2.S274]Open DOISearch in Google Scholar
[28. Shenberg E, Torten M. A new leptospiral vaccine for use in man. I. Development of a vaccine from Leptospira grown in a chemicacally defined medium. J Inf Dis.1973; 128:642-6.10.1093/infdis/128.5.642]Open DOISearch in Google Scholar
[29. Levett P, Morey R, Gallowway R, Turner D, Steigerwalt A, Mayer L. Detection of pathogenic leptospires by real-time quantitative real-time PCR. J Med Microbiol. 2005; 54:45-9.10.1099/jmm.0.45860-0]Open DOISearch in Google Scholar
[30. Matsunaga J, Barocchi M, Croda J, Young T, Sanchez Y, Siqueira I. Pathogenic Leptospira species express surface-exposed proteins belonging to the bacterial immunoglobulin superfamily. Molecul Microbiol. 2003; 49:929-46.10.1046/j.1365-2958.2003.03619.x]Open DOISearch in Google Scholar
[31. Choy H, Kelley M, Chen T, Moller A, Matsunaga J, Haake D. Physiological osmotic induction of Leptospira interrogans adhesion: LigA and LigB bind extracellular matrix proteins and fibrinogen. Infect Immun. 2007; 75:2441-50.10.1128/IAI.01635-06]Open DOISearch in Google Scholar
[32. Gonzalez A, Rodriguez Y, Batista N, Valdes Y, Nu ez J, Gonzalez M. Booster effect of an active immunization with Leptospira interrogans serogroup Ballum in hamsters vaccinated with vax-SPIRAL. Vacci Monitor. 2003; 12:1-6.]Search in Google Scholar
[33. Faine S, Adler B, Bolin C, Perolat P: Leptospira and Leptospirosis. 2nd edition. Melbourne, Australia: MediSci; 1999.]Search in Google Scholar
[34. Sonrier C, Branger C, Michel V, Ruvoen N, Ganiere J, Andre G. Evidence of cross-protection within Leptospira interrogans in an experimental model. Vaccine. 2000; 19:86-94.10.1016/S0264-410X(00)00129-8]Open DOISearch in Google Scholar
[35. Coutinho ML, Choy HA, Kelley MM, Matsunaga J, Babbitt JT, Lewis M, Aleixo JA, Haake D. A LigA Three- Domain Region Protects Hamsters from Lethal Infection by Leptospira interrogans. PLoS Negl Trop Dis. 2011; 5:e1422. 10.1371/journal.pntd.0001422323672122180800]Open DOISearch in Google Scholar